Finding growth in food and farming stocks
Professional investor Mayssa Al Midani of the Pictet Nutrition Fund picks three of her favourites companies helping to fix our fraught food systems.
In the next three decades, the world will have an extra 1.5 billion mouths to feed. That is a big challenge with current resources within the context of two simultaneous crises – one environmental, the other a so-called “double burden of malnutrition”, in which some two billion people are obese or overweight while a similar number suffer from insufficient access to nutrition.
There is growing demand for food to be healthy and nutritious, as well as for production methods to be sustainable. These trends have been accelerated by the pandemic. From farm to fork, there are opportunities for investors to tap into companies providing solutions to our fraught food systems – the best way of addressing global environmental and health challenges simultaneously.
Boosting crop yields
With limited scope to increase arable land, we need technology to boost productivity and yields. This is supported by EU and US policies to promote resource efficiency in agriculture while reducing the use of chemical pesticides and antimicrobials.Covid-19 has highlighted the link between poor diets and vulnerability to disease. Policymakers are pushing for reduced levels of sugar, salt and saturated fats while consumers are opting for foods and supplements offering benefits such as improved immunity.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
A growing number of companies are capitalising on the opportunity to feed the world in a healthy and sustainable manner. John Deere (NYSE: DE) is the world’s leading equipment manufacturer in the precision-agriculture sector. Appetite for new equipment is high given an ageing fleet (the oldest it has been in 30 years) and a growing awareness of the economic and environmental benefits of precision agriculture. Profitability in farming has returned to levels last seen in the 2011-2014 supercycle given high crop prices and strong harvests, making equipment upgrades more affordable.
A pet-health provider in pole position
In animal health, Zoetis (NYSE: ZTS), the biggest producer of medical treatments for pets and livestock, is well positioned to capitalise on market growth given its broad portfolio of blockbuster drugs, world-class manufacturing operations, speed to market and innovation capabilities. Its diagnostics business adds a new layer of superior growth and recurring revenues, allowing for preventative care of animals. US-based Zoetis has best-in-class margins among its peers and should continue to expand thanks to operating leverage and pricing power from innovation.
Finally, in the nutrition sector, DSM (Amsterdam: DSM) stands out for particularly innovative products. For humans, these include dietary supplements, fermented stevia (tastier, healthier versions of traditional sweeteners) and human-milk oligosaccharides (a collection of carbohydrate structures that may help support immunity and gut health).
The Dutch firm also specialises in animal nutrition, as its headline-grabbing “Clean Cow” initiative demonstrates. It involves the addition of a feed supplement that DSM says can reduce the amount of methane cows release into the air by at least 30%. The innovative portfolio of products, together with underlying portfolio organic growth, should underpin double-digit medium-term earnings growth.
• Mayssa Al Midani was recently a guest on the MoneyWeek Podcast. Listen to the episode here
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Mayssa Al Midani is senior investment manager at the Pictet Nutrition Fund
-
How to invest in frontier markets
Frontier markets can be extremely risky, but they offer access to exotic stocks in rapidly developing countries
By David C. Stevenson Published
-
Should you put your trust in investment trusts?
British investors have steered clear of investment trusts in recent years. They are missing a trick, says Max King
By Max King Published
-
How to invest in frontier markets
Frontier markets can be extremely risky, but they offer access to exotic stocks in rapidly developing countries
By David C. Stevenson Published
-
Should you put your trust in investment trusts?
British investors have steered clear of investment trusts in recent years. They are missing a trick, says Max King
By Max King Published
-
Renewable energy investing: who is paying for the green revolution?
Investors in renewables have not been rewarded, says Bruce Packard. Will they fund the government’s plans?
By Bruce Packard Published
-
The best ways to invest in Vietnam – Asia’s communist dynamo
Vietnam has long been one of our favourite markets. The prognosis remains auspicious, says Alex Rankine.
By Alex Rankine Published
-
India is a new global powerhouse — should you invest?
India’s growth rate has slowed recently, but there is still ample scope for investors to benefit from its development.
By David Prosser Published
-
Why Chinese stocks are so far out of favour
There’s little appetite for Chinese stocks despite low valuations.
By Cris Sholto Heaton Published
-
Three companies that dominate their markets with critical products
A professional investor tells us where he’d put his money. This week: Charlie Huggins, manager of Wealth Club’s Quality Shares Portfolio, picks three stocks.
By Charlie Huggins Published
-
Should you continue to hold Smithson Investment Trust?
Opinion Smithson Investment Trust, a small- and mid-cap fund, has struggled to live up to lofty expectations, says Rupert Hargreaves.
By Rupert Hargreaves Published